Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (2809)	7/8/1998 12:19:00 PM
From: Gwolf	Respond to of 5402

He did say that they would be publishing in medical journals and such approximately three months after the animal trials begin. When that occurs he anticipated that the major drug companies would coming knocking on his door to look at funding through joint ventures or outright buy out proposals. Dr. Drees stated that he didn't want to sell out because of the potential for the product but did say that if they shoved enough money down his throat it would force him to shut up. Gwolf